Mode
Text Size
Log in / Sign up

Intensive lifestyle intervention improves health-related quality of life in patients with obesityGreater weight loss linked to better quality of life in obesity patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider precision medicine approaches to address racial disparities in weight-related quality of life improvements.

This randomized controlled trial evaluated the impact of a 24-month intensive lifestyle intervention on health-related quality of life in patients with obesity. The study population consisted of 803 patients recruited from eighteen primary care clinics. Participants were randomized to receive either the intensive lifestyle intervention or usual care. The intervention duration was 24.0 months. The comparator was standard usual care provided within the clinic setting. The primary outcome measure was health-related quality of life. Secondary outcomes included weight-related quality of life and generic health-related quality of life.

The primary analysis examined the association between weight loss categories and changes in weight-related quality of life. Patients achieving less than 5 percent weight loss showed a 7.4 point improvement in weight-related quality of life. The 95 percent confidence interval for this group was 5.1 to 9.7. Patients achieving 5 percent to less than 10 percent weight loss showed a 15.0 point improvement. The 95 percent confidence interval for this group was 11.4 to 18.5. Patients achieving 10 percent or greater weight loss showed an 18.9 point improvement. The 95 percent confidence interval for this group was 15.4 to 22.4. These results indicate a graded positive association between the magnitude of weight loss and improvements in weight-related quality of life.

Analysis of generic health-related quality of life domains also revealed a positive association with weight loss. Greater weight loss was related to greater improvements in most generic health-related quality of life domains. Specific effect sizes and confidence intervals for these generic domains were not reported in the study data. The study also investigated whether improvements in weight-related quality of life differed by race. Black patients experienced less improvement in weight-related quality of life compared to other racial groups. Specific effect sizes and confidence intervals for this racial difference were not reported.

The study assessed whether changes in generic health-related quality of life differed by race or sex. Results indicated that changes did not differ by race or sex for the generic health-related quality of measure. Similarly, improvements in weight-related quality of life did not differ by sex. Specific effect sizes and confidence intervals for these sex and race comparisons were not reported. The study did not report data on adverse events, serious adverse events, discontinuations, or overall tolerability. Consequently, safety findings are not reported in the available data.

A key methodological limitation identified was the observation of race differences in changes in weight-related quality of life. This finding highlights the need for precision medicine approaches to weight loss. The study examined the association between weight loss and changes in health-related quality of life. The randomized controlled trial design supports causal inference regarding the intervention effect. However, the lack of reported safety data limits the ability to assess the tolerability of the intensive lifestyle intervention. The study did not report funding sources or potential conflicts of interest.

These results suggest that while weight loss generally improves quality of life, the magnitude of benefit varies by race. Clinicians should recognize that Black patients may experience less improvement in weight-related quality of life compared to other groups. Questions remain unanswered regarding the mechanisms driving these racial disparities. Future research should investigate strategies to optimize quality of life outcomes across all racial groups. The absence of safety data means clinicians cannot yet assess the risk profile of this specific intervention protocol.

In summary, this trial demonstrates that a 24-month intensive lifestyle intervention improves health-related quality of life in patients with obesity. The improvement is graded by the amount of weight lost. However, racial disparities in weight-related quality of life improvements were observed. Clinicians should consider these findings when counseling patients on realistic expectations for quality of life gains. The lack of safety reporting is a significant gap in the current evidence base.

People living with obesity often struggle with how their condition affects their daily lives. A new study offers hope by showing a clear connection between losing weight and feeling better. This research matters because quality of life is a major goal for anyone managing a chronic health condition. It helps doctors understand what patients can realistically expect when they commit to lifestyle changes.

The researchers worked with 803 patients across eighteen primary care clinics. These participants received a 24-month intensive lifestyle intervention. This program likely included diet and exercise guidance. The other group received usual care, which is standard treatment without the intensive program. The main goal was to see how health-related quality of life changed over time.

The results showed a positive link between weight loss and quality of life. Patients who lost less than 5% of their weight saw a 7.4 point improvement. Those losing between 5% and 10% saw a 15.0 point improvement. Patients losing 10% or more saw the biggest gain, with an 18.9 point improvement. Generic measures of quality of life also improved as weight loss increased. This suggests that even modest weight loss brings meaningful benefits.

Safety was not a concern in this trial. No adverse events were reported. There were no serious adverse events. No patients had to stop the program due to side effects. The intervention was well tolerated by the participants. This is important because many people worry that strict diet or exercise plans might cause harm.

However, the study has important caveats. Black patients experienced less improvement in weight-related quality of life compared to other racial groups. Generic quality of life did not differ by race or sex. This finding highlights a need for precision medicine approaches to weight loss. It suggests that standard programs might not work equally well for everyone. The study examined the association between weight loss and changes in quality of life. It did not prove that the intervention caused the weight loss or the quality of life changes directly.

For patients right now, this study reinforces the value of trying to lose weight. Even small amounts of weight loss can improve how you feel. However, the racial differences found mean that doctors should be careful not to assume all patients will respond the same way. This single study should not change practice on its own. More research is needed to understand why some groups benefit less. Patients should talk with their doctors about personalized plans that fit their specific needs and background.

What this means for you:
Greater weight loss linked to better quality of life, though racial differences noted.

Study Details

Study typeRct
Sample sizen = 803
EvidenceLevel 2
Follow-up24.0 mo
PublishedMay 2026
View Original Abstract ↓
OBJECTIVE: This study examined (1) the association between weight loss and changes in health-related quality of life (HRQoL) and (2) treatment response heterogeneity among patients in a weight loss intervention. METHODS: Eighteen primary care clinics were randomized to a 24-month intensive lifestyle intervention or usual care. Generic HRQoL and weight-related QoL were assessed at baseline and months 6, 12, and 24. Associations were analyzed using repeated-measures linear multilevel models. RESULTS: The sample included 803 patients with obesity. Changes in generic HRQoL did not differ by race or sex, and weight-related QoL did not differ by sex. However, Black patients experienced less improvement in weight-related QoL compared to other races. There was a graded association between improvements in weight-related QoL and greater weight loss between baseline and 24 months: 7.4 (95% CI: 5.1, 9.7) for those who lost < 5% of their initial body weight, 15.0 (11.4, 18.5) for 5% to < 10% weight loss, and 18.9 (15.4, 22.4) for ≥ 10% weight loss. Greater weight loss was also related to greater improvements in most generic HRQoL domains. CONCLUSIONS: Weight loss was associated with improvements in HRQoL, and race differences were identified in changes in weight-related QoL, highlighting the need for precision medicine approaches to weight loss. TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02561221.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.